Citas
<!--[if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:TargetScreenSize>800x600</o:TargetScreenSize> </o:OfficeDocumentSettings> </xml><![endif]--> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">1. Bousser MG, Ferro JM: Cerebral venous thrombosis: an update. Lancet Neurology 6:162– 170, 2007 </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">2. <strong><span style="mso-spacerun: yes;"> </span></strong></span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Einhäupl K, , J. Stamb, M. -G. Bousser et al.<span style="mso-spacerun: yes;"> </span>EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. European Journal of Neurology 2010,<span style="mso-spacerun: yes;"> </span>17: 1229–1235 </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;"> </span></span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">3. Saposnik, G, Barinagarrementeria F, Brown R, Jr et al. Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92. </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">4. Ferro JM, Canhão P, Stam J, et al. <span style="mso-bidi-font-weight: bold;">Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) </span><em>Stroke </em>2004;35;664-670;</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">5. Cerobrovascular Disease. 2009. Kaplan, Chapter 16. Cerebral Venous Thrombosis. 554-577 </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: FR;" lang="FR">6. <span style="mso-bidi-font-weight: bold;">Aaron S, Alexander M, Maya T, et al. </span></span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">Underlying<span style="mso-spacerun: yes;"> </span>prothrombotic states in pregnancy associated cerebral venous thrombosis. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Neurology India | Jul-Aug 2010 | Vol 58 | Issue 4</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">7. Ferro JM, Lopes MG. VENOPORT. Delay in hospital admision of patients<span style="mso-spacerun: yes;"> </span>with cerebral vein and dural sinus thrombosis<span style="mso-spacerun: yes;"> </span>Cerebrovas<span style="mso-spacerun: yes;"> </span>Dis<span style="mso-spacerun: yes;"> </span>2005,19:152-156</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">8. <span style="mso-bidi-font-weight: bold;">Stam J: Thrombosis of the cerebral veins and sinuses. N Engl</span><span style="mso-spacerun: yes;"> </span><span style="mso-bidi-font-weight: bold;">J Med 352:1791–1798, 2005</span></span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">9. Ferro JM, Canhao P, Stam J, et al. Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke 2009; 40: 3133-3138</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">10. Masuhr F, Mehraein S, Einhäupl K: Cerebral venous and sinusthrombosis. J Neurol 251:11–23, 2004</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">11. Provenzale J, Kranz P. Dural Sinus Thrombosis: Sources of Error in Image Interpretation. Neuroradiology AJR 2011; 196: 23-31</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">12. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Giraldo E, Petrinjac, Nenadic R, The ‘‘Cord Sign’’ in Cerebral Venous Thrombosis Associated with High Plasma Levels of Factor VIII. Neurocritical Care DOI 10.1007/s12028-2010-9434-2</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">13. Liauw L, van Buchem MA, Spilt A, de Bruine FT, van den Berg R, Hermans J, et al. MR </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">angiography of the intracraneal venous system. Radiology. 2000;214:678—82</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">14. Canho P, Ferro JM,<span style="mso-spacerun: yes;"> </span>Lindgren A, Causes and predictors of Death in Cerebral</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Venous Thrombosis. Stroke 2005,36;1720-1725</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">15. Preter M, Tzourio CH, Ameri A, Bousser MG. Long term prognosis in cerebral venous thrombosis: a follow-up of 77 patients. <em>Stroke</em>. 1996;27:243–246.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">16. de Bruijn SFTM, de Haan RJ, Stam J, for the Cerebral Venous Sinus Thrombosis Study Group. Clinical features and prognostic factors ofcerebral venous sinus thrombosis in a prospective series of 59 patients. <em>J Neurol Neurosurg Psychiatry</em>. 2001;70:105–108.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">17. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J, for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group (VENOPORT). Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT Study. <em>Cerebrovasc Dis</em>. 2002;13:272–278.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">18. Ferro<span style="mso-spacerun: yes;"> </span>JM,<span style="mso-spacerun: yes;"> </span>Canha˜o P, <span style="mso-bidi-font-weight: bold;">Complications of Cerebral Vein and</span> <span style="mso-bidi-font-weight: bold;">Sinus Thrombosis . </span>Handbook on Cerebral Venous Thrombosis. Front Neurol Neurosci. Basel, Karger, 2008, vol 23, pp 161–171</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">19. Lamy C, Hamon JB, Costa J, Mas JL, for the French Study Group on Stroke in Pregnancy. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. <em>Neurology</em>. 2000;55:269–274.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">20. Farrag A, Irfan M, Guliani G; et al.<span style="mso-spacerun: yes;"> </span>Occurrence of Post-Acute Recanalization and Collateral Formation in Patients with Cerebral Venous and Sinus Thrombosis. A Serial Venographic Study. Neurocrit Care DOI 10.1007/s12028-010-9394-6. </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;"> </span></span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">21. Einha¨ upl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597–600.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; tab-stops: 370.95pt; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-tab-count: 1;"> </span></span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">22. De Bruijn SFTM, Stam J, for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo controlled trial of anticoagulant treatment with lowmolecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484–488.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">23. Stam J, de Bruijn SFTM, deVeber G. Anticoagulation for cerebral sinus thrombosis. The Cochrane Database of Systematic Reviews Issue 4. 2001: Art. No.: CD002005.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">24. <span style="mso-bidi-font-weight: bold;">Coutinho J, de Bruijn SFTM, deVeber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis (Review). </span>The Cochrane Collaboration. Published in <span style="mso-bidi-font-style: italic;">The Cochrane Library</span>2011, Issue 8</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">25. Girot M, Ferro JM, Canhão P, et al.: ISCVT Investigators: <span style="mso-bidi-font-weight: bold;">Predictors of outcome in patients with cerebral venous</span> <span style="mso-bidi-font-weight: bold;">thrombosis and intracerebral hemorrhage. </span><em>Stroke </em>2007, <span style="mso-bidi-font-weight: bold;">38:</span>337–342.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">26. Ferro JM and Canhao P. Acute Treatment of Cerebral Venous and Dural Sinus Thrombosis. <span style="mso-bidi-font-weight: bold;">Current Treatment Options in Neurology </span>2008, <span style="mso-bidi-font-weight: bold;">10:</span>126–137</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">27. Fuentes B, Martinez-Sanchez P, García Raya P, Abenza MJ, Diez Tejedor E. Cerebral Venous Sinus Thrombosis Associated With Cerebral Hemorrhage. Is Anticoagulant Treatment Safe? <em>The Neurologist </em>2011;17:208–210.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">28. Coutinho J, Ferro JM, Canhao P, et al. Unfractined or Low Molecular Weight Heparin for the Treatment of Cerebral Venous Thrombosis. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: SV;" lang="SV">Stroke 2010; 41: 2575-2580.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: SV;" lang="SV"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: SV;" lang="SV">29. Van Dongen CJJ, van den Belt AGM, Prins MH, Lensing AWA. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. The Cochrane Database of Systematic Reviews Issue 4. 2004: Art. No.: CD001100.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: IT;" lang="IT">30.. Dentali F, Squizzato A, Gianni M et al. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Safety of thrombolissys in cerebral venous thrombosis. A systematic review of the literature. Thromb Haemost 2010; 104</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">31. Einha¨ upl KM, Masuhr F. Cerebral venous and sinus thrombosis – an update. Eur J Neurol 1994; 1: 109–126.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">32. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992; 10: 87–111.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">33. Ferro JM, Canha˜o P, Bousser MG, Stam J, Barinagarrementeria F, for the ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 2008; 39: 1152–1158.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">34. Canha˜o P, Cortesa˜o A, Cabral M, et al., for the ISCVT Investigators Are steroids useful to treat cerebral venous thrombosis? Stroke 2008; 39: 105–110.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">35. The´audin M; Crassard I, ; Bresson D, et al. <span style="mso-bidi-font-weight: bold;">Should Decompressive Surgery Be<strong> </strong>Performed in Malignant Cerebral Venous Thrombosis? <em>Stroke</em>. 2010;41:727-731.</span></span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">36. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Vahedi K, Hofmeijer J, Juettler E, Vicaut E, et al. DECIMAL, DESTINY, and HAMLET investigators Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: FR; mso-bidi-font-style: italic;" lang="FR">Lancet</span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: FR;" lang="FR"> <span style="mso-bidi-font-style: italic;">Neurol</span>. 2007;6:215–222.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: FR; mso-bidi-font-weight: bold;" lang="FR"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: FR; mso-bidi-font-weight: bold;" lang="FR">37. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: FR;" lang="FR"><span style="mso-spacerun: yes;"> </span>Ferro JM, Crassard I, Coutinho JM, et al. </span><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US">Decompressive Surgery in Cerebrovenous Thrombosis : A Multicenter Registry and a Systematic Review of Individual Patient Data. </span><em><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">Stroke </span></em><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">2011, 42:2825-2831:</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;" lang="EN-US"> </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 150%; text-autospace: ideograph-numeric;"><span style="font-family: "Arial","sans-serif"; mso-ansi-language: EN-US;" lang="EN-US">38. Mohindra S, Umredkar A, Navneet S, Bal A and Gupta S. Decompressive craniectomy for malignant cerebral oedema of cortical venous thrombosis: an analysis of 13 patients.<span style="mso-spacerun: yes;"> </span>British Journal of Neurosurgery, June 2011; 25(3): 422–429</span></p>